Since 1997, SL Pharma Labs has provided high value drug product development, analytical, microbiological and early phase clinical manufacturing services for parenteral, liquid and topical products. SL Pharma Labs mission is to support clients in meeting product development, analysis, regulatory approval and commercialization timelines and budgetary requirements.

What differentiates SL Pharma Labs from other contract research and development organizations?

• experienced scientists and leadership from industry that understand the challenges of drug product development and commercialization processes in today's highly regulated market
• adaptive and customized approach to the unique needs of every client, drug product and project
• reliable partner that is committed to meeting client budget and timing requirements
• collaborative project design and completion from start to finish
• track record of consistent high quality and GMP-Compliance

SL Pharma Labs has a team of experienced pharmaceutical and biotechnology industry leaders with deep knowledge and commitment to outstanding service. The company’s mission is to maintain small, agile project teams that collaborate with clients to assure that all projects are completed efficiently and meeting all project scope requirements.

News May 2011 SL Pharma Labs is pleased to continue its excellent record and history with the FDA. The company successfully completed FDA pre-approval inspection (PAI) for another client's parenteral drug product. In addition, the FDA conducted a comprehensive GMP compliance inspection including quality systems. January 2011 Expansion of the Class 100 - Class 100,000 cleanroom capabilities to service a growing number of start-up and virtual clients needs in early phase clinical manufacture of parenterals and topical products has been completed by SL Pharma Labs. In addition, analytical capabilities have been enhanced to support product development and clinical manufacture in large molecule client projects.